nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—SLC15A2—choroid plexus—malignant glioma	0.102	0.308	CbGeAlD
Tranexamic Acid—PLG—endothelium—malignant glioma	0.0499	0.151	CbGeAlD
Tranexamic Acid—PLG—blood vessel—malignant glioma	0.046	0.14	CbGeAlD
Tranexamic Acid—PLG—embryo—malignant glioma	0.0275	0.0833	CbGeAlD
Tranexamic Acid—PLG—retina—malignant glioma	0.0243	0.0737	CbGeAlD
Tranexamic Acid—Hemiparesis—Temozolomide—malignant glioma	0.0201	0.13	CcSEcCtD
Tranexamic Acid—PLG—spinal cord—malignant glioma	0.0156	0.0475	CbGeAlD
Tranexamic Acid—PLG—central nervous system—malignant glioma	0.0127	0.0385	CbGeAlD
Tranexamic Acid—PLG—brain—malignant glioma	0.0101	0.0306	CbGeAlD
Tranexamic Acid—PLG—Orphan transporters—APOD—malignant glioma	0.00843	0.0163	CbGpPWpGaD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—F2—malignant glioma	0.00818	0.0158	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP3—malignant glioma	0.00801	0.0155	CbGpPWpGaD
Tranexamic Acid—PLG—Blood Clotting Cascade—F2—malignant glioma	0.00789	0.0153	CbGpPWpGaD
Tranexamic Acid—SLC15A2—retina—malignant glioma	0.00776	0.0236	CbGeAlD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—PTK2—malignant glioma	0.00771	0.0149	CbGpPWpGaD
Tranexamic Acid—SLC15A2—telencephalon—malignant glioma	0.00714	0.0217	CbGeAlD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP2—malignant glioma	0.00694	0.0134	CbGpPWpGaD
Tranexamic Acid—Deep vein thrombosis—Temozolomide—malignant glioma	0.00691	0.0449	CcSEcCtD
Tranexamic Acid—Embolism—Temozolomide—malignant glioma	0.00655	0.0426	CcSEcCtD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—FGFR1—malignant glioma	0.00644	0.0125	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—malignant glioma	0.00644	0.0125	CbGpPWpGaD
Tranexamic Acid—Digestion impaired—Temozolomide—malignant glioma	0.00629	0.0409	CcSEcCtD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—FN1—malignant glioma	0.00584	0.0113	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—F2—malignant glioma	0.00584	0.0113	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD1—malignant glioma	0.00578	0.0112	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—YWHAE—malignant glioma	0.00572	0.0111	CbGpPWpGaD
Tranexamic Acid—SLC15A2—medulla oblongata—malignant glioma	0.00561	0.017	CbGeAlD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—KNG1—malignant glioma	0.00554	0.0107	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PTK2—malignant glioma	0.0054	0.0104	CbGpPWpGaD
Tranexamic Acid—SLC15A2—midbrain—malignant glioma	0.00513	0.0156	CbGeAlD
Tranexamic Acid—SLC15A2—spinal cord—malignant glioma	0.005	0.0152	CbGeAlD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CTSB—malignant glioma	0.00496	0.00961	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP2—malignant glioma	0.00495	0.00959	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP2—malignant glioma	0.00495	0.00959	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS1—malignant glioma	0.00493	0.00955	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—FGF2—malignant glioma	0.00471	0.00911	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SOD1—malignant glioma	0.0047	0.00911	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—malignant glioma	0.0047	0.0091	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—NTRK1—malignant glioma	0.00466	0.00902	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—CAT—malignant glioma	0.00447	0.00865	CbGpPWpGaD
Tranexamic Acid—Pulmonary embolism—Carmustine—malignant glioma	0.00435	0.0283	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—KNG1—malignant glioma	0.00434	0.00841	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—MMP3—malignant glioma	0.00433	0.00839	CbGpPWpGaD
Tranexamic Acid—Respiratory failure—Temozolomide—malignant glioma	0.00428	0.0278	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Temozolomide—malignant glioma	0.00426	0.0277	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Temozolomide—malignant glioma	0.00421	0.0273	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—KNG1—malignant glioma	0.00414	0.00801	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00413	0.00799	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—BCAN—malignant glioma	0.00411	0.00796	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—FN1—malignant glioma	0.00409	0.00791	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—F2—malignant glioma	0.00409	0.00791	CbGpPWpGaD
Tranexamic Acid—SLC15A2—central nervous system—malignant glioma	0.00406	0.0123	CbGeAlD
Tranexamic Acid—PLG—Platelet degranulation—SOD1—malignant glioma	0.00403	0.00781	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—DOCK6—malignant glioma	0.00403	0.00781	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—F2—malignant glioma	0.00402	0.00779	CbGpPWpGaD
Tranexamic Acid—SLC15A2—cerebellum—malignant glioma	0.00397	0.012	CbGeAlD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PTPN11—malignant glioma	0.00384	0.00744	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.00384	0.00744	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD1—malignant glioma	0.00374	0.00724	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP9—malignant glioma	0.00372	0.00721	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—malignant glioma	0.00372	0.00721	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—malignant glioma	0.00372	0.00721	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—F2—malignant glioma	0.00358	0.00693	CbGpPWpGaD
Tranexamic Acid—Swelling—Carmustine—malignant glioma	0.00358	0.0233	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CAT—malignant glioma	0.00355	0.00687	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP3—malignant glioma	0.00353	0.00684	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—malignant glioma	0.00347	0.00671	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—FGF2—malignant glioma	0.00329	0.00638	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—F2—malignant glioma	0.00327	0.00634	CbGpPWpGaD
Tranexamic Acid—SLC15A2—brain—malignant glioma	0.00322	0.00978	CbGeAlD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—BAD—malignant glioma	0.00312	0.00604	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—PDGFB—malignant glioma	0.00311	0.00602	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—SPP1—malignant glioma	0.00309	0.00598	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IFNG—malignant glioma	0.00305	0.0059	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—malignant glioma	0.003	0.0058	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.00296	0.00574	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—malignant glioma	0.00287	0.00555	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—FN1—malignant glioma	0.00281	0.00543	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL1B—malignant glioma	0.00272	0.00527	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.00267	0.00518	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—EGF—malignant glioma	0.00266	0.00514	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00265	0.00512	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—F2—malignant glioma	0.0026	0.00504	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.00253	0.0049	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IFNG—malignant glioma	0.00248	0.0048	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ATP1B2—malignant glioma	0.00244	0.00473	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00243	0.00471	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—malignant glioma	0.00242	0.00469	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00242	0.00469	CbGpPWpGaD
Tranexamic Acid—Renal failure—Carmustine—malignant glioma	0.00239	0.0155	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00231	0.00447	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL1B—malignant glioma	0.00221	0.00428	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TNC—malignant glioma	0.00221	0.00428	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Temozolomide—malignant glioma	0.00221	0.0143	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL2—malignant glioma	0.00221	0.00427	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Carmustine—malignant glioma	0.0022	0.0143	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP2—malignant glioma	0.00219	0.00423	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Carmustine—malignant glioma	0.00219	0.0142	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—CASP3—malignant glioma	0.00213	0.00413	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Temozolomide—malignant glioma	0.00212	0.0138	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00212	0.0041	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Temozolomide—malignant glioma	0.00211	0.0137	CcSEcCtD
Tranexamic Acid—Visual impairment—Carmustine—malignant glioma	0.00211	0.0137	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CTSB—malignant glioma	0.00208	0.00403	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOD—malignant glioma	0.00206	0.00398	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Carmustine—malignant glioma	0.00204	0.0133	CcSEcCtD
Tranexamic Acid—Visual impairment—Temozolomide—malignant glioma	0.00203	0.0132	CcSEcCtD
Tranexamic Acid—Flushing—Carmustine—malignant glioma	0.00203	0.0132	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—malignant glioma	0.00201	0.00388	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—malignant glioma	0.00197	0.00382	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Temozolomide—malignant glioma	0.00197	0.0128	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IFNG—malignant glioma	0.00197	0.00382	CbGpPWpGaD
Tranexamic Acid—Flushing—Temozolomide—malignant glioma	0.00196	0.0127	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Temozolomide—malignant glioma	0.00196	0.0127	CcSEcCtD
Tranexamic Acid—Arrhythmia—Carmustine—malignant glioma	0.00195	0.0127	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.00193	0.00373	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Temozolomide—malignant glioma	0.00192	0.0124	CcSEcCtD
Tranexamic Acid—Immune system disorder—Temozolomide—malignant glioma	0.00191	0.0124	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Temozolomide—malignant glioma	0.0019	0.0124	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—malignant glioma	0.00189	0.00366	CbGpPWpGaD
Tranexamic Acid—Back pain—Carmustine—malignant glioma	0.00184	0.012	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—malignant glioma	0.00183	0.00354	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ANGPT2—malignant glioma	0.0018	0.00349	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PDGFRA—malignant glioma	0.0018	0.00348	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.00179	0.00346	CbGpPWpGaD
Tranexamic Acid—Back pain—Temozolomide—malignant glioma	0.00178	0.0116	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL1B—malignant glioma	0.00176	0.0034	CbGpPWpGaD
Tranexamic Acid—Anaemia—Carmustine—malignant glioma	0.00176	0.0114	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—SPP1—malignant glioma	0.00174	0.00337	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CASP3—malignant glioma	0.00174	0.00337	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—XBP1—malignant glioma	0.00174	0.00337	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Temozolomide—malignant glioma	0.00171	0.0111	CcSEcCtD
Tranexamic Acid—Anaemia—Temozolomide—malignant glioma	0.0017	0.011	CcSEcCtD
Tranexamic Acid—Malaise—Temozolomide—malignant glioma	0.00166	0.0108	CcSEcCtD
Tranexamic Acid—Convulsion—Carmustine—malignant glioma	0.00165	0.0107	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.00164	0.00318	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—malignant glioma	0.00164	0.00318	CbGpPWpGaD
Tranexamic Acid—Chest pain—Carmustine—malignant glioma	0.00162	0.0105	CcSEcCtD
Tranexamic Acid—Myalgia—Carmustine—malignant glioma	0.00162	0.0105	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PDGFB—malignant glioma	0.00161	0.00312	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—malignant glioma	0.00161	0.00311	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—malignant glioma	0.00161	0.00311	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGFR1—malignant glioma	0.0016	0.00311	CbGpPWpGaD
Tranexamic Acid—Convulsion—Temozolomide—malignant glioma	0.00159	0.0103	CcSEcCtD
Tranexamic Acid—Myalgia—Temozolomide—malignant glioma	0.00156	0.0102	CcSEcCtD
Tranexamic Acid—Arthralgia—Temozolomide—malignant glioma	0.00156	0.0102	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—HIST1H3B—malignant glioma	0.00156	0.00302	CbGpPWpGaD
Tranexamic Acid—Discomfort—Temozolomide—malignant glioma	0.00155	0.01	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MYB—malignant glioma	0.00155	0.00299	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LATS2—malignant glioma	0.00153	0.00297	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.00153	0.00296	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00151	0.00292	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Temozolomide—malignant glioma	0.0015	0.00975	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.00149	0.00289	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP3—malignant glioma	0.00148	0.00287	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Temozolomide—malignant glioma	0.00147	0.00956	CcSEcCtD
Tranexamic Acid—Hypotension—Carmustine—malignant glioma	0.00145	0.00943	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—BAD—malignant glioma	0.00144	0.00278	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TP53—malignant glioma	0.00142	0.00274	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00141	0.00919	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—malignant glioma	0.00141	0.00273	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CD80—malignant glioma	0.00139	0.0027	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Carmustine—malignant glioma	0.00138	0.00899	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00138	0.00267	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.00138	0.00267	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGF—malignant glioma	0.00138	0.00266	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTPN11—malignant glioma	0.00137	0.00265	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00137	0.00888	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—malignant glioma	0.00137	0.00265	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Carmustine—malignant glioma	0.00134	0.00871	CcSEcCtD
Tranexamic Acid—Dyspnoea—Temozolomide—malignant glioma	0.00134	0.00869	CcSEcCtD
Tranexamic Acid—Dyspepsia—Temozolomide—malignant glioma	0.00132	0.00858	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0013	0.00842	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—SPP1—malignant glioma	0.00129	0.00251	CbGpPWpGaD
Tranexamic Acid—Fatigue—Temozolomide—malignant glioma	0.00129	0.0084	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—SPHK1—malignant glioma	0.00129	0.0025	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Carmustine—malignant glioma	0.00128	0.00831	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—malignant glioma	0.00128	0.00247	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT2—malignant glioma	0.00127	0.00247	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Carmustine—malignant glioma	0.00127	0.00825	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.00125	0.00241	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—F2—malignant glioma	0.00125	0.00241	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Temozolomide—malignant glioma	0.00124	0.00803	CcSEcCtD
Tranexamic Acid—Abdominal pain—Carmustine—malignant glioma	0.00123	0.00797	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Temozolomide—malignant glioma	0.00123	0.00797	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CD—malignant glioma	0.00122	0.00237	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00121	0.00234	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—H3F3A—malignant glioma	0.00121	0.00233	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—PDGFB—malignant glioma	0.0012	0.00232	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.00119	0.00231	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Temozolomide—malignant glioma	0.00119	0.00771	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.00118	0.00228	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00117	0.00227	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGF2—malignant glioma	0.00117	0.00227	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LATS1—malignant glioma	0.00116	0.00225	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—malignant glioma	0.00115	0.00223	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Carmustine—malignant glioma	0.00114	0.00743	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—KDR—malignant glioma	0.00112	0.00217	CbGpPWpGaD
Tranexamic Acid—Asthenia—Carmustine—malignant glioma	0.00111	0.00724	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Temozolomide—malignant glioma	0.00111	0.00718	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MDM2—malignant glioma	0.0011	0.00212	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—RAF1—malignant glioma	0.00109	0.00211	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.00109	0.00211	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00109	0.0021	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—malignant glioma	0.00108	0.00209	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FN1—malignant glioma	0.00108	0.00209	CbGpPWpGaD
Tranexamic Acid—Asthenia—Temozolomide—malignant glioma	0.00108	0.00699	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—malignant glioma	0.00107	0.00206	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Carmustine—malignant glioma	0.00106	0.0069	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00105	0.00204	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.00105	0.00203	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00103	0.002	CbGpPWpGaD
Tranexamic Acid—Dizziness—Carmustine—malignant glioma	0.00103	0.00667	CcSEcCtD
Tranexamic Acid—Diarrhoea—Temozolomide—malignant glioma	0.00103	0.00667	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—KNG1—malignant glioma	0.000993	0.00192	CbGpPWpGaD
Tranexamic Acid—Dizziness—Temozolomide—malignant glioma	0.000992	0.00645	CcSEcCtD
Tranexamic Acid—Vomiting—Carmustine—malignant glioma	0.000987	0.00641	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IFNA2—malignant glioma	0.000973	0.00188	CbGpPWpGaD
Tranexamic Acid—Headache—Carmustine—malignant glioma	0.000973	0.00632	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000967	0.00187	CbGpPWpGaD
Tranexamic Acid—Vomiting—Temozolomide—malignant glioma	0.000954	0.0062	CcSEcCtD
Tranexamic Acid—Headache—Temozolomide—malignant glioma	0.00094	0.00611	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000935	0.00181	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SOD1—malignant glioma	0.000922	0.00179	CbGpPWpGaD
Tranexamic Acid—Nausea—Carmustine—malignant glioma	0.000922	0.00599	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—malignant glioma	0.000922	0.00178	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000921	0.00178	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—malignant glioma	0.000916	0.00177	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000913	0.00177	CbGpPWpGaD
Tranexamic Acid—Nausea—Temozolomide—malignant glioma	0.000891	0.00579	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—BCHE—malignant glioma	0.00089	0.00172	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—FBXW7—malignant glioma	0.000876	0.00169	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FGF2—malignant glioma	0.00087	0.00168	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PTK2—malignant glioma	0.000847	0.00164	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000839	0.00162	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—malignant glioma	0.000824	0.0016	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDK—malignant glioma	0.000785	0.00152	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DTX1—malignant glioma	0.000749	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—malignant glioma	0.000749	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—malignant glioma	0.000729	0.00141	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000713	0.00138	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PDGFB—malignant glioma	0.000712	0.00138	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—malignant glioma	0.000708	0.00137	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—malignant glioma	0.000688	0.00133	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CAV1—malignant glioma	0.000674	0.00131	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—malignant glioma	0.00065	0.00126	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—F2—malignant glioma	0.000642	0.00124	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FN1—malignant glioma	0.000642	0.00124	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—malignant glioma	0.000614	0.00119	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—EGF—malignant glioma	0.000607	0.00118	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PTPN11—malignant glioma	0.000603	0.00117	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000601	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SUFU—malignant glioma	0.000595	0.00115	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HEY2—malignant glioma	0.000588	0.00114	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GFAP—malignant glioma	0.000574	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT2—malignant glioma	0.000562	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000557	0.00108	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPHK1—malignant glioma	0.000556	0.00108	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000552	0.00107	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HEY1—malignant glioma	0.000544	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCR4—malignant glioma	0.000544	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—malignant glioma	0.00054	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—malignant glioma	0.000531	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIST1H3B—malignant glioma	0.000529	0.00102	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000526	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—F2—malignant glioma	0.000505	0.000977	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAG2—malignant glioma	0.000483	0.000935	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAF1—malignant glioma	0.000482	0.000933	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—malignant glioma	0.000471	0.000911	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000455	0.00088	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL2—malignant glioma	0.000432	0.000837	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—malignant glioma	0.000428	0.000829	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000417	0.000808	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—H3F3A—malignant glioma	0.000409	0.000791	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR3—malignant glioma	0.000405	0.000783	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NTRK2—malignant glioma	0.000394	0.000762	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—YWHAE—malignant glioma	0.000394	0.000762	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FLT1—malignant glioma	0.000392	0.000759	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DUSP6—malignant glioma	0.00039	0.000755	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAG1—malignant glioma	0.000385	0.000746	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH3—malignant glioma	0.000384	0.000742	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FBXW7—malignant glioma	0.000377	0.00073	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BDKRB2—malignant glioma	0.00037	0.000716	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—malignant glioma	0.000367	0.000711	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—malignant glioma	0.000356	0.000689	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH2—malignant glioma	0.000344	0.000666	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KNG1—malignant glioma	0.000337	0.000652	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NTRK1—malignant glioma	0.000321	0.000621	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KRAS—malignant glioma	0.000312	0.000605	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP3—malignant glioma	0.000298	0.000577	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN2B—malignant glioma	0.000296	0.000572	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTK2—malignant glioma	0.000287	0.000556	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—malignant glioma	0.000287	0.000555	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HES1—malignant glioma	0.000282	0.000546	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NCOR1—malignant glioma	0.00028	0.000543	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—malignant glioma	0.000278	0.000537	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDGFRA—malignant glioma	0.000269	0.00052	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPP1—malignant glioma	0.000261	0.000505	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TERT—malignant glioma	0.000247	0.000478	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDGFB—malignant glioma	0.000241	0.000467	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR1—malignant glioma	0.00024	0.000465	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000238	0.000461	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—malignant glioma	0.000236	0.000458	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—malignant glioma	0.000234	0.000454	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CAV1—malignant glioma	0.000229	0.000443	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KDR—malignant glioma	0.000226	0.000438	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FN1—malignant glioma	0.000218	0.000421	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—F2—malignant glioma	0.000218	0.000421	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BAD—malignant glioma	0.000215	0.000416	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH1—malignant glioma	0.000213	0.000412	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CD80—malignant glioma	0.000209	0.000404	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—malignant glioma	0.000208	0.000403	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—malignant glioma	0.000208	0.000403	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGF—malignant glioma	0.000206	0.000398	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTPN11—malignant glioma	0.000205	0.000396	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BRAF—malignant glioma	0.000196	0.000379	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT2—malignant glioma	0.000191	0.000369	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—malignant glioma	0.000183	0.000354	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF2—malignant glioma	0.000175	0.000339	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—malignant glioma	0.000164	0.000317	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAF1—malignant glioma	0.000163	0.000316	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—malignant glioma	0.000162	0.000313	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—malignant glioma	0.00016	0.000309	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—malignant glioma	0.000153	0.000297	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—malignant glioma	0.000147	0.000284	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—malignant glioma	0.000147	0.000284	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—malignant glioma	0.000139	0.000268	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—malignant glioma	0.000138	0.000267	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—malignant glioma	0.000125	0.000241	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—malignant glioma	0.000123	0.000239	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—malignant glioma	0.000115	0.000222	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—malignant glioma	0.000112	0.000217	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—malignant glioma	0.000106	0.000205	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—malignant glioma	9.73e-05	0.000188	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—malignant glioma	9.41e-05	0.000182	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—malignant glioma	7.95e-05	0.000154	CbGpPWpGaD
